Checking AGIO unusual options activity helps you spot when traders are making outsized bets on Agios Pharmaceuticals Inc before the broader market catches on. Agios Pharmaceuticals Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor AGIO unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching AGIO unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking AGIO unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and AGIO unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Catalysts rarely arrive without a footprint, and AGIO unusual options activity is often where that footprint shows up first. Our scanner tracks Agios Pharmaceuticals Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at AGIO unusual options volume on the call side or chasing put sweeps, Agios Pharmaceuticals Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
